Status:
UNKNOWN
Hydroxychloroquine Efficacy on Behcet's Disease Thrombosis
Lead Sponsor:
Assiut University
Conditions:
Behcet's Syndrome, Vascular Type
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients diagnosed with Behcet's disease will be randomized to administeration of hydroxychloroquine. Assessment will be done for the patients at baseline and every one month in the first three months...
Eligibility Criteria
Inclusion
- All patients diagnosed with Behcet's disease on any DMARDs
Exclusion
- Patients with critical conditions
- Patients with hypersensitivity or adverse drug reactions to hydroxychloroquine.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04022421
Start Date
October 1 2018
End Date
October 1 2019
Last Update
July 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospital
Asyut, Egypt